Clinical Trials & Medical Discoveries Headlines from PR Newswire

< Go Back

Albert Einstein College of Medicine and Montefiore Health System Name New Chair of Obstetrics & Gynecology and Women's Health
Cardio3 Biosciences Announces the Enrolment of the 240th Patient for its CHART-1 Phase III Clinical Trial for the Treatment of Heart Failure
Blackrock Microsystems Launches Wireless Brain Research System
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer
Three Somagenics Publications Demonstrate Successful Inhibition of the Hepatitis C Virus by Therapeutic sshRNA™ and Confirm Mechanism of Action
Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I
OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer
CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in the EU
Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union
RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound
Sorrento and Conkwest Announce Exclusive Global Collaboration
New Possibilities in the Fight Against Pancreatic Cancer
Cells identified that enhance tumor growth and suppress anti-cancer immune attack
Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis
Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug Designation in the United States and the European Union for the Treatment of Malignant Pleural Mesothelioma
AMC Health Names Paul Argay Chief Marketing Officer, Adding to Strong Executive Management Team
Self-Reported Daily Exercise Associated with Lower Blood Pressure, Glucose Readings in Adults
US Nonprofit Awards Italian Biotech Additional Funding to Study New Class of Drugs to Treat Alzheimer's Disease
Parent Project Muscular Dystrophy and Solid Ventures Partner on Solid Suit, an Assistive Device for Duchenne Muscular Dystrophy to be Developed by SRI International
Advanced Molecular Diagnostics Company, Admera Health, Implements WaferGen's Next-Generation Sequencing Sample Prep Platform for Clinical Testing
$12M Investment in Orphan Drug Company Nutrinia, Brings Hope to Pre-term and Short Bowel Syndrome Infants
New Report: Decades of Drug Research Failures and Successes Transform Hepatitis C from Incurable to Curable Disease
Kalorama: Market For Testing On Tissues and Cells Reaches 7.5 Billion-Dollars
D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA
Valkee Bright Light Headset Demonstrates Alleviation of Jet Lag Symptoms
Nuvo Research® reports that all patients have completed Phase 2 study of WF10™ for the treatment of allergic rhinitis
Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A through Two Peer-Reviewed Publications Spanish
Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL™ Nausea Relief
Successful FDA Inspection at Hovione
First Patient Treated in Mapi Pharma's Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)
Study Published In The New England Journal Of Medicine Finds Intra-Arterial Treatment For Clot Removal Is More Effective At Treating Stroke Than Standard Medical Care Spanish
Groundbreaking Study Confirms That Neurointerventional Surgery Provides Significant Clinical Benefit
Hepatitis C Therapies: World Industry, R&D and Market Forecasts 2015-2025
VolitionRx to Initiate Study with University Hospital Bonn to Confirm NuQ® Test Accuracy in Lung Cancer
Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus
Bayer Submits Biologics License Application for BAY 81-8973 for the Treatment of Hemophilia A in Adults and Children
Clementia Pharmaceuticals Initiates First Prospective Natural History Study in Patients with Fibrodysplasia Ossificans Progressiva (FOP) Portuguese Spanish Spanish
RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301
First European Approval for Implant Made of PEEK-OPTIMA® HA Enhanced
Aratana Therapeutics Initiates Pivotal Study for AT-003
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) for Hemophilia B Patients
Americord Funds Clinical Trial Examining the Use of Donor Stem Cells in Patients with Previously Treated Cancers
HedgePath Pharmaceuticals Receives IND Clearance to Commence Development of its Proposed Cancer Treatment
United States Patent Office Grants Apnea Sciences Patent
NewGen Therapeutics Targeted Anti-Cancer Drug, NT-113, Demonstrates Compelling Activity in Glioblastoma Xenograft Models
SOV Therapeutics announces Successful Phase IIb Study of Oral Testosterone Undecanoate for Treatment of Primary and Secondary Hypogonadism in Adult Males
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer
VirtualScopics Licences IXICO's Proprietary TrialTracker™ Digital Platform

< Prev Next >
PR Newswire - United Business Media